Araris Biotech AG’s Post

Learn how our experts can support your #antibody drug conjugate (ADC) program at any stage, from antibody discovery, to safety and efficacy characterization, and beyond: https://okt.to/n4WyCr

Learn how our experts can support your #antibody drug conjugate (ADC) program at any stage, from antibody discovery, to safety and efficacy characterization, and beyond: https://okt.to/pn9LP0

Discover new disease-linked targets! Early choices in drug discovery significantly impact success or failure. Identifying the right druggable target is crucial. Explore our extensive portfolio of products and services for antibody drug discovery. Download our brochure and receive an Antibody pin! https://lnkd.in/eG6KJp2d #alwayscurious

Discover new disease-linked targets! Early choices in drug discovery significantly impact success or failure. Identifying the right druggable target is crucial. Explore our extensive portfolio of products and services for antibody drug discovery. Download our brochure and receive an Antibody pin! https://lnkd.in/gquDTazT #alwayscurious

Discover new disease-linked targets! Early choices in drug discovery significantly impact success or failure. Identifying the right druggable target is crucial. Explore our extensive portfolio of products and services for antibody drug discovery. Download our brochure and receive an Antibody pin! https://lnkd.in/e8NaHQwe #alwayscurious

South Korean life sciences are booming. With a strong connection between Monoclonal Antibodies and antibody therapies, 40% of its bioprocessing players are involved. Bigger image they're drawing? Longer, more thoughtful fathoms, now Antibody Drug Conjugates, form the enormous foreland of joy and hope. Discover the unfolding realm's mechanics and gain power at https://lnkd.in/gFPDgb5g.

Macrocycles - The next wave of drug discovery. While the continued exploration of antibody drug conjugates (ADCs) is useful in the discovery of new mechanisms to treat platinum resistant disease, challenges of unavoidable, off-target toxicities persist. The industry at-large has begun to look towards macrocycle development, with Merck citing macrocycles as “the next wave of drug discovery.” Macrocycles are chemically complex cyclic molecules that combine the benefits of large and small molecules which include an extensive binding capacity to challenging targets, potent anti-tumor activity, favorable pharmacokinetic properties and an improved safety profile compared to ADCs. Texaphyrin Drug Conjugates (TDCs) are macrocycles.

It's the last day of Festival of Biologics! If you missed our poster session with Juliana Campo Garcia yesterday on “Mastering Multi-Specific Antibody Production for Next-Gen Drug Discovery with TurboCHO™” and you want to learn more about our TurboCHO platform, please visit our Booth #526! Why not grab yourself a GenScript goodie whilst you're there? #FestivalofBiologics #FOB2024 #bioengineering #proteinengineering #antibody #antibodyengineering #drugdevelopment

Download our latest factsheet to learn all about our end-to-end capabilities for Antibody Drug Conjugate development. 🧪💊 Our team of experts is here to guide you through every step of the process, from biochemical to in vivo testing. Click the link below to get your copy now! Download now: https://hubs.ly/Q02zfdb70 #ADC #drugdevelopment #payload #antigen #antibody 🚀🔬

In her presentation at Festival of Biologics, Salma Jalal will discuss how #MassPhotometry enables fast, straightforward characterization of therapeutic antibody samples while consuming very little sample. 🧪 Additionally, you will hear how the data obtained through mass photometry compares to and complements SEC-UV for quantifying antibody aggregation. 📊🔬 Bring your questions at booth #1000!